Cases 101 - 110 of 143
Acura Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
as 1:2012cv01372
Plaintiff:
Acura Pharmaceuticals Inc.
Defendant:
Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc.
Counter_defendant:
Acura Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PURDUE PHARMACEUTICAL PRODUCTS L.P. et al v. PAR PHARMACEUTICAL, INC.
as 2:2012cv06738
Plaintiff:
PURDUE PHARMACEUTICAL PRODUCTS L.P. , PURDUE PHARMA L.P. and TRANSCEPT PHARMACEUTICALS, INC.
Defendant:
PAR PHARMACEUTICAL, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc. et al
as 1:2012cv01123
Plaintiff:
Avanir Pharmaceuticals Inc.
Defendant:
Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_claimant:
Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_defendant:
Avanir Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Watson Laboratories, Inc.
as 1:2012cv00517
Plaintiff:
Bayer Pharma AG, Bayer Intellectual Property GMBH and Bayer HealthCare Pharmaceuticals Inc.
Defendant:
Watson Pharmaceuticals Inc., Watson Pharma Inc., Actavis Pharma Inc. and others
Cause Of Action: 35 U.S.C. § 271
DEPOMED, INC. v. IMPAX LABORATORIES, INC. et al
as 3:2012cv02154
Plaintiff:
DEPOMED, INC.
Defendant:
IMPAX LABORATORIES, INC. , PAR PHARMACEUTICAL COMPANIES, INC. and PAR PHARMACEUTICAL, INC.
Counter_claimant:
PAR PHARMACEUTICAL COMPANIES, INC. and PAR PHARMACEUTICAL, INC.
Counter_defendant:
DEPOMED, INC.
Cause Of Action: 35 U.S.C. § 145
AR Holding Company Inc. v. Par Pharmaceutical Inc.
as 1:2012cv00419
Plaintiff:
AR Holding Company Inc.
Defendant:
Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc.
Counter_defendant:
AR Holding Company Inc.
Cause Of Action: 35 U.S.C. § 271
Horizon Pharma Inc. et al v. Par Pharmaceutical Companies Inc. et al
as 1:2012cv00393
Plaintiff:
Horizon Pharma Inc. and Horizon Pharma USA Inc.
Defendant:
Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_defendant:
Horizon Pharma USA Inc. and Horizon Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
Alkermes Pharma Ireland Limited v. Par Pharmaceutical Inc.
as 1:2011cv01119
Plaintiff:
Alkermes Pharma Ireland Limited
Defendant:
Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION et al v. PAR PHARMACEUTICAL, INC.
as 2:2011cv06640
Plaintiff:
CELGENE CORPORATION , NOVARTIS PHARMACEUTICALS CORPORATION and NOVARTIS PHARMA AG
Defendant:
PAR PHARMACEUTICAL, INC.
Cause Of Action: 35 U.S.C. § 271
PAR Pharmaceutical, Inc. et al v. TWI Pharmaceuticals, Inc
as 1:2011cv06134
Plaintiff:
PAR Pharmaceutical, Inc. and EDT Pharma Holdings Ltd
Defendant:
TWI Pharmaceuticals, Inc
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
